TABLE 3

Treatment of AOM

Results
Antibiotic choice and duration
 Antibiotics used, n (%)
  Amoxicillin679 (81)
  Amoxicillin and clavulanate144 (17)
  Ceftriaxone97 (12)
  Cefdinir66 (8)
  Other oral cephalosporins12 (1)
  Ampicillin8 (<1)
  Ampicillin and sulbactam7 (<1)
  Azithromycin5 (<1)
  Ciprofloxacin2 (<1)
  Clindamycin1 (<1)
 Total duration of treatment, preadmission, inpatient, and discharge prescription in d, mean ± SD
  Overall8.9 + 3.1
  <2 y old (n = 602)9.1 + 3.1
  2–5 y old (n = 205)8.7 + 3.0
  >6 y old (n = 33)8.3 + 3.5
 Duration of discharge prescription from inpatient setting in d, mean ± SD
  Overall6.7 ± 2.2
  <2 y old (n = 602)6.6 + 2.2
  2–5 y old (n = 205)6.7 + 2.1
  >6 y old (n = 33)6.7 + 2.6
Treatment appropriateness
 Patients who qualified for wait-and-watch, n (%)
  Overall91 (11)
  <2 y old (n = 602)7 (1)
  2–5 y old (n = 205)70 (34)
  >6 y old (n = 33)14 (42)
 No. (%) patients receiving excess duration; attributable excess DOTsa
  Overall320 (38); 825
  <2 y old (n = 602)146 (24); 286
  2–5 y old (n = 205)151 (74); 465
  >6 y old (n = 33)23 (70); 74
 No. (%) patients without documented bulging of the TM; attributable excess DOTsb
  Overall394 (47); 3417
  <2 y old (n = 602)283 (37); 2500
  2–5 y old (n = 205)87 (10); 712
  >6 y old (n = 33)24 (3); 205
  • Episodes of AOM: N = 840.

  • a Based on 10 (age <2 y) or 7 DOTs (age ≥2 y).

  • b Based on considering those without bulging (47%) as not qualifying for treatment plus excess DOTs in those with bulging.